14.19
Schlusskurs vom Vortag:
$13.34
Offen:
$13.34
24-Stunden-Volumen:
196.15K
Relative Volume:
1.44
Marktkapitalisierung:
$133.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.17M
KGV:
-1.4002
EPS:
-10.1344
Netto-Cashflow:
$-82.84M
1W Leistung:
+12.09%
1M Leistung:
+14.90%
6M Leistung:
-62.77%
1J Leistung:
-70.67%
Korro Bio Inc Stock (KRRO) Company Profile
Firmenname
Korro Bio Inc
Sektor
Branche
Telefon
617-468-1999
Adresse
60 FIRST STREET, CAMBRIDGE
Vergleichen Sie KRRO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
KRRO
Korro Bio Inc
|
14.19 | 118.88M | 0 | -81.17M | -82.84M | -10.13 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
2025-04-16 | Eingeleitet | Chardan Capital Markets | Buy |
2025-01-10 | Eingeleitet | Oppenheimer | Outperform |
2024-10-21 | Eingeleitet | Raymond James | Strong Buy |
2024-08-14 | Eingeleitet | William Blair | Outperform |
2024-03-28 | Bestätigt | H.C. Wainwright | Buy |
2024-02-27 | Eingeleitet | BMO Capital Markets | Outperform |
2023-12-04 | Eingeleitet | H.C. Wainwright | Buy |
2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
2023-11-10 | Eingeleitet | Piper Sandler | Overweight |
2023-02-15 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
2023-02-13 | Herabstufung | Cowen | Outperform → Market Perform |
2021-09-22 | Herabstufung | Goldman | Buy → Neutral |
2021-01-27 | Hochstufung | JP Morgan | Neutral → Overweight |
2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
2020-07-14 | Eingeleitet | Oppenheimer | Outperform |
2020-05-18 | Herabstufung | JP Morgan | Overweight → Neutral |
2019-10-28 | Eingeleitet | Cowen | Outperform |
2019-10-28 | Eingeleitet | Goldman | Buy |
2019-10-28 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Korro Bio Inc Aktie (KRRO) Neueste Nachrichten
Is Korro Bio Inc. a good long term investmentRapidly growing investment returns - jammulinksnews.com
Korro Bio Inc. Stock Analysis and ForecastSuperior capital gains - jammulinksnews.com
What analysts say about Korro Bio Inc. stockSuperior stock growth - jammulinksnews.com
Korro Bio stock steady as H.C. Wainwright reiterates Buy rating - Investing.com
Korro Bio receives EMA orphan drug designation for AATD treatment - Investing.com India
Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110 - The Manila Times
Korro Achieves Crucial EMA Orphan Drug Status for AATD Treatment, Following FDA Recognition - Stock Titan
What drives Korro Bio Inc. stock priceTremendous growth potential - jammulinksnews.com
What makes Korro Bio Inc. stock attractive to long term investorsRapid Gain Targets - Newser
What risks could impact Korro Bio Inc. stock performanceSmart Growth Low Risk Picks - Newser
How Korro Bio Inc. stock performs during market volatilityFree Access to Community - Newser
What makes Korro Bio Inc. stock price move sharplyStrong Buy Recommendations - Newser
Why Korro Bio Inc. stock attracts strong analyst attentionEarly Breakout Tracker - Newser
Korro Bio, Inc.(NasdaqCM: KRRO) dropped from Russell Small Cap Comp Growth Index - MarketScreener
Korro Bio, Inc. (NASDAQ:KRRO) Shares Acquired by California State Teachers Retirement System - Defense World
Cantor Fitzgerald Estimates Korro Bio FY2026 Earnings - Defense World
Wellington Management Group LLP Raises Stock Holdings in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Nuveen Asset Management LLC Purchases 17,131 Shares of Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Jane Street Group LLC Makes New Investment in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Deutsche Bank AG Buys 935 Shares of Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of “Buy” from Analysts - Defense World
KRRO stock touches 52-week low at $11.06 amid sharp annual decline By Investing.com - Investing.com South Africa
KRRO stock touches 52-week low at $11.06 amid sharp annual decline - Investing.com Nigeria
Korro Bio, Inc. (NASDAQ:KRRO) Shares Purchased by BNP Paribas Financial Markets - Defense World
Korro Bio’s SWOT analysis: RNA editing pioneer’s stock faces pivotal year By Investing.com - Investing.com South Africa
Korro Bio’s SWOT analysis: RNA editing pioneer’s stock faces pivotal year - Investing.com India
Korro Bio, Inc. (NASDAQ:KRRO) Stock Position Boosted by Northern Trust Corp - Defense World
Finance Watch: Prime, Kyverna, Allogene And More Announce Job Cuts - insights.citeline.com
Brokers Offer Predictions for Korro Bio FY2025 Earnings - Defense World
Balyasny Asset Management L.P. Makes New Investment in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Korro to Participate in Upcoming Investor Conferences - The Manila Times
Korro Bio Leadership Takes Stage at Three Major Healthcare Conferences: RBC, Jefferies, and Goldman Sachs - Stock Titan
Korro Bio (KRRO) Rating and Price Target Maintained by Chardan C - GuruFocus
Finanzdaten der Korro Bio Inc-Aktie (KRRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Korro Bio Inc-Aktie (KRRO) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Agarwal Vineet | Chief Financial Officer |
Nov 11 '24 |
Sale |
70.00 |
800 |
56,000 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):